MedPath
NMPA Approval

Letermovir Tablets

国药准字HJ20210085

December 31, 2021

Drug Information

来特莫韦片

普瑞明

片剂

240mg

化学药品

December 31, 2021

December 30, 2026

Company Information

Applicant Company

Waarderweg 39, 2031 BN Haarlem, The Netherlands

Manufacturing Company

msd international gmbh t/a msd ireland (ballydine)

Kilsheelan, Clonmel, Co. Tipperary, Ireland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

来特莫韦片 - NMPA 批准文号 | MedPath